Your browser doesn't support javascript.
loading
Expanding the clinical phenotype of IARS2-related mitochondrial disease.
Vona, Barbara; Maroofian, Reza; Bellacchio, Emanuele; Najafi, Maryam; Thompson, Kyle; Alahmad, Ahmad; He, Langping; Ahangari, Najmeh; Rad, Abolfazl; Shahrokhzadeh, Sima; Bahena, Paulina; Mittag, Falk; Traub, Frank; Movaffagh, Jebrail; Amiri, Nafise; Doosti, Mohammad; Boostani, Reza; Shirzadeh, Ebrahim; Haaf, Thomas; Diodato, Daria; Schmidts, Miriam; Taylor, Robert W; Karimiani, Ehsan Ghayoor.
Afiliação
  • Vona B; Institute of Human Genetics, Julius Maximilians University Würzburg, Würzburg, Germany. barbara.vona@uni-wuerzburg.de.
  • Maroofian R; Department of Otorhinolaryngology, Head and Neck Surgery, Tübingen Hearing Research Centre (THRC), Eberhard Karls University Tübingen, 72076, Tübingen, Germany. barbara.vona@uni-wuerzburg.de.
  • Bellacchio E; Genetics and Molecular Cell Sciences Research Centre, St George's, University of London, Cranmer Terrace, London, SW17 0RE, UK.
  • Najafi M; Genetics and Rare Diseases, Research Division, 'Bambino Gesù' Children Hospital, Rome, Italy.
  • Thompson K; Genome Research Division, Human Genetics Department, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Geert Grooteplein Zuid 10, 6525KL, Nijmegen, The Netherlands.
  • Alahmad A; Wellcome Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
  • He L; Wellcome Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
  • Ahangari N; Wellcome Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
  • Rad A; Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Shahrokhzadeh S; Next Generation Genetic Clinic, Mashhad, Iran.
  • Bahena P; Genome Research Division, Human Genetics Department, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Geert Grooteplein Zuid 10, 6525KL, Nijmegen, The Netherlands.
  • Mittag F; Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran.
  • Traub F; Next Generation Genetic Clinic, Mashhad, Iran.
  • Movaffagh J; Institute of Human Genetics, Julius Maximilians University Würzburg, Würzburg, Germany.
  • Amiri N; Department of Orthopaedic Surgery, University Hospital of Tübingen, Hoppe-Seyler-Strasse 3, 72076, Tübingen, Germany.
  • Doosti M; Department of Orthopaedic Surgery, University Hospital of Tübingen, Hoppe-Seyler-Strasse 3, 72076, Tübingen, Germany.
  • Boostani R; Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, University of Medical Sciences, Mashhad, Iran.
  • Shirzadeh E; Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, University of Medical Sciences, Mashhad, Iran.
  • Haaf T; Next Generation Genetic Clinic, Mashhad, Iran.
  • Diodato D; Department of Neurology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Schmidts M; Sabzevar University of Medical Sciences, Sabzevar, Iran.
  • Taylor RW; Institute of Human Genetics, Julius Maximilians University Würzburg, Würzburg, Germany.
  • Karimiani EG; Unit of Neuromuscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, 'Bambino Gesu' Children's Research Hospital, Rome, Italy.
BMC Med Genet ; 19(1): 196, 2018 11 12.
Article em En | MEDLINE | ID: mdl-30419932
ABSTRACT

BACKGROUND:

IARS2 encodes a mitochondrial isoleucyl-tRNA synthetase, a highly conserved nuclear-encoded enzyme required for the charging of tRNAs with their cognate amino acid for translation. Recently, pathogenic IARS2 variants have been identified in a number of patients presenting broad clinical phenotypes with autosomal recessive inheritance. These phenotypes range from Leigh and West syndrome to a new syndrome abbreviated CAGSSS that is characterised by cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, as well as cataract with no additional anomalies.

METHODS:

Genomic DNA from Iranian probands from two families with consanguineous parental background and overlapping CAGSSS features were subjected to exome sequencing and bioinformatics analysis.

RESULTS:

Exome sequencing and data analysis revealed a novel homozygous missense variant (c.2625C > T, p.Pro909Ser, NM_018060.3) within a 14.3 Mb run of homozygosity in proband 1 and a novel homozygous missense variant (c.2282A > G, p.His761Arg) residing in an ~ 8 Mb region of homozygosity in a proband of the second family. Patient-derived fibroblasts from proband 1 showed normal respiratory chain enzyme activity, as well as unchanged oxidative phosphorylation protein subunits and IARS2 levels. Homology modelling of the known and novel amino acid residue substitutions in IARS2 provided insight into the possible consequence of these variants on function and structure of the protein.

CONCLUSIONS:

This study further expands the phenotypic spectrum of IARS2 pathogenic variants to include two patients (patients 2 and 3) with cataract and skeletal dysplasia and no other features of CAGSSS to the possible presentation of the defects in IARS2. Additionally, this study suggests that adult patients with CAGSSS may manifest central adrenal insufficiency and type II esophageal achalasia and proposes that a variable sensorineural hearing loss onset, proportionate short stature, polyneuropathy, and mild dysmorphic features are possible, as seen in patient 1. Our findings support that even though biallelic IARS2 pathogenic variants can result in a distinctive, clinically recognisable phenotype in humans, it can also show a wide range of clinical presentation from severe pediatric neurological disorders of Leigh and West syndrome to both non-syndromic cataract and cataract accompanied by skeletal dysplasia.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças do Desenvolvimento Ósseo / Catarata / Neuropatias Hereditárias Sensoriais e Autônomas / Doença de Leigh / Doenças Mitocondriais / Perda Auditiva Neurossensorial / Isoleucina-tRNA Ligase Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças do Desenvolvimento Ósseo / Catarata / Neuropatias Hereditárias Sensoriais e Autônomas / Doença de Leigh / Doenças Mitocondriais / Perda Auditiva Neurossensorial / Isoleucina-tRNA Ligase Idioma: En Ano de publicação: 2018 Tipo de documento: Article